Insider Trading History of Tarriff Scott


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tarriff Scott since year 2005. The trader's CIK number is 1469124. At the time of the last reporting, Tarriff Scott was the CEO of Eagle Pharmaceuticals, Inc. . (stock ticker symbol EGRX). See this page for all insider trading activities at Eagle Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Tarriff Scott since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-04-01 EGRX Eagle Pharmaceuticals, Inc. Sale 24,975 50.15 1,252,496
2019-03-01 EGRX Eagle Pharmaceuticals, Inc. Sale 24,428 51.16 1,249,736
2019-02-01 EGRX Eagle Pharmaceuticals, Inc. Sale 30,085 41.91 1,260,862
2019-01-02 EGRX Eagle Pharmaceuticals, Inc. Sale 15,000 39.66 594,975
2019-01-03 EGRX Eagle Pharmaceuticals, Inc. Sale 16,569 39.77 658,949
2018-06-28 EGRX Eagle Pharmaceuticals, Inc. Option Ex 124,804 4.04 504,208
2018-03-30 EGRX Eagle Pharmaceuticals, Inc. Option Ex 113,104 4.04 456,940
2016-04-01 EGRX Eagle Pharmaceuticals, Inc. Sale 30,765 40.63 1,249,981
2016-02-01 EGRX Eagle Pharmaceuticals, Inc. Sale 18,360 68.76 1,262,433
2016-01-04 EGRX Eagle Pharmaceuticals, Inc. Sale 14,549 86.33 1,256,087
2015-12-01 EGRX Eagle Pharmaceuticals, Inc. Sale 14,050 89.20 1,253,316
2015-11-02 EGRX Eagle Pharmaceuticals, Inc. Sale 19,339 64.78 1,252,877
2015-10-01 EGRX Eagle Pharmaceuticals, Inc. Sale 17,878 71.02 1,269,606
2015-09-01 EGRX Eagle Pharmaceuticals, Inc. Sale 16,245 76.50 1,242,823
2015-08-03 EGRX Eagle Pharmaceuticals, Inc. Sale 13,000 95.88 1,246,375
2015-07-01 EGRX Eagle Pharmaceuticals, Inc. Sale 15,710 79.58 1,250,280
2015-03-20 EGRX Eagle Pharmaceuticals, Inc. Sale 120,000 42.00 5,040,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tarriff Scott (CEO of Eagle Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.